Quantum-Si (NASDAQ:QSI) Trading Down 2.4%
Shares of Quantum-Si (NASDAQ:QSI) fell 2.4% during trading, reaching a low of {{.Question}}.91 and last trading at {{.Question}}.92. The trading volume was 259,096 shares, down 64% from the average. The company reported a negative net margin of 5,249.65% and a negative return on equity of 33.02%. Director Charles R. Kummeth purchased 31,100 shares at an average cost of {{.Question}}.89. Institutional investors hold 39.90% of the stock. Quantum-Si focuses on developing a single-molecule detection platform for Next Generation Protein Sequencing.
Shares of Quantum-Si incorporated (NASDAQ:QSI - Get Free Report) fell 2.4% during trading on Wednesday . The stock traded as low as $0.91 and last traded at $0.92. 259,096 shares traded hands during trading, a decline of 64% from the average session volume of 717,433 shares. The stock had previously closed at $0.94.
Quantum-Si Stock Down 2.4 %
- Penny Stock Quantum-Si Incorporated Readies For Lift-Off
The company has a 50 day simple moving average of $0.98 and a 200 day simple moving average of $1.41. The company has a market capitalization of $130.47 million, a price-to-earnings ratio of -1.42 and a beta of 2.87.
Quantum-Si (NASDAQ:QSI - Get Free Report) last announced its quarterly earnings results on Wednesday, August 7th. The company reported ($0.16) earnings per share for the quarter, beating analysts' consensus estimates of ($0.21) by $0.05. Quantum-Si had a negative net margin of 5,249.65% and a negative return on equity of 33.02%. The firm had revenue of $0.62 million for the quarter, compared to analysts' expectations of $0.66 million. On average, research analysts forecast that Quantum-Si incorporated will post -0.71 EPS for the current fiscal year.
Insiders Place Their Bets
In other Quantum-Si news, Director Charles R. Kummeth bought 31,100 shares of the business's stock in a transaction on Monday, August 12th. The shares were bought at an average cost of $0.89 per share, with a total value of $27,679.00. Following the transaction, the director now directly owns 355,000 shares in the company, valued at approximately $315,950. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. In other news, Director Charles R. Kummeth purchased 31,100 shares of the firm's stock in a transaction that occurred on Monday, August 12th. The stock was acquired at an average cost of $0.89 per share, for a total transaction of $27,679.00. Following the completion of the purchase, the director now owns 355,000 shares of the company's stock, valued at $315,950. The purchase was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Also, Director Charles R. Kummeth acquired 138,900 shares of the stock in a transaction that occurred on Friday, August 9th. The stock was purchased at an average cost of $0.87 per share, with a total value of $120,843.00. Following the completion of the acquisition, the director now owns 323,900 shares of the company's stock, valued at $281,793. The disclosure for this purchase can be found here. Insiders purchased a total of 245,000 shares of company stock worth $213,522 in the last 90 days. 30.04% of the stock is owned by company insiders.
Hedge Funds Weigh In On Quantum-Si
Institutional investors have recently made changes to their positions in the stock. Public Employees Retirement System of Ohio bought a new stake in shares of Quantum-Si during the first quarter valued at approximately $27,000. Simplicity Wealth LLC bought a new stake in Quantum-Si during the 1st quarter valued at $28,000. Bleakley Financial Group LLC acquired a new position in Quantum-Si during the 1st quarter worth $28,000. XTX Topco Ltd bought a new position in shares of Quantum-Si in the second quarter worth $25,000. Finally, Virtu Financial LLC bought a new stake in shares of Quantum-Si during the first quarter valued at about $98,000. 39.90% of the stock is owned by institutional investors.
Quantum-Si Company Profile
(Get Free Report)Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company's platform is comprised of the Platinum NGPS instrument; the Platinum Analysis Software service; and reagent kits and semiconductor chips for use with its instruments.
Further Reading
- Five stocks we like better than Quantum-Si
- 3 Grocery Stocks That Are Proving They Are Still Essential
- Goldilocks CPI Report Leads Market to Sell Off, Lower Lows Ahead
- Canadian Penny Stocks: Can They Make You Rich?
- GameStop: Earnings Won’t Save It, Dilution Points to Trouble
- Consumer Discretionary Stocks Explained
- Dividend Aristocrats or Dividend Kings: Which Is Best for You?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
→ Preferred Stock Offer: Get an 8% dividend yield opportunity on this robotics stock (From Deal Maker) (Ad)
Should you invest $1,000 in Quantum-Si right now?
Before you consider Quantum-Si, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum-Si wasn't on the list.
While Quantum-Si currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
